These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35018451)
21. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ; Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875 [TBL] [Abstract][Full Text] [Related]
22. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation. Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436 [TBL] [Abstract][Full Text] [Related]
23. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964 [TBL] [Abstract][Full Text] [Related]
25. Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults. Burns EM; Guroji P; Ahmad I; Nasr HM; Wang Y; Tamimi IA; Stiefel E; Abdelgawwad MS; Shaheen A; Muzaffar AF; Bush LM; Hurst CB; Griffin RL; Elmets CA; Yusuf N JAMA Dermatol; 2017 Oct; 153(10):983-989. PubMed ID: 28832880 [TBL] [Abstract][Full Text] [Related]
26. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea. Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609 [TBL] [Abstract][Full Text] [Related]
27. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan. Wang CC; Tang CH; Wang CY; Huang SY; Sue YM Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242 [TBL] [Abstract][Full Text] [Related]
28. Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA J Crohns Colitis; 2019 Aug; 13(8):1036-1043. PubMed ID: 30689765 [TBL] [Abstract][Full Text] [Related]
30. Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis. Gil-Quiñones SR; Sepúlveda-Pachón IT; Sánchez Vanegas G; Gutierrez-Castañeda LD PLoS One; 2021; 16(11):e0258499. PubMed ID: 34735462 [TBL] [Abstract][Full Text] [Related]
31. Nonmelanoma skin cancer and risk for subsequent malignancy. Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282 [TBL] [Abstract][Full Text] [Related]
32. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. Ariyaratnam J; Subramanian V Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479 [TBL] [Abstract][Full Text] [Related]
33. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study. Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank. Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937 [TBL] [Abstract][Full Text] [Related]
35. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900 [TBL] [Abstract][Full Text] [Related]
36. Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. Besson C; Moore A; Wu W; Vajdic CM; de Sanjose S; Camp NJ; Smedby KE; Shanafelt TD; Morton LM; Brewer JD; Zablotska L; Engels EA; Cerhan JR; Slager SL; Han J; Berndt SI; Int J Epidemiol; 2021 Aug; 50(4):1325-1334. PubMed ID: 33748835 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389 [TBL] [Abstract][Full Text] [Related]
39. High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals. Winsløw UC; Nordestgaard BG; Afzal S Br J Dermatol; 2018 Jun; 178(6):1388-1395. PubMed ID: 29143981 [TBL] [Abstract][Full Text] [Related]
40. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. Wheless L; Kistner-Griffin E; Jorgensen TJ; Ruczinski I; Berthier-Schaad Y; Kessing B; Hoffman-Bolton J; Francis L; Shugart YY; Strickland PT; Kao WH; Alani RM; Smith MW; Alberg AJ J Invest Dermatol; 2012 May; 132(5):1354-62. PubMed ID: 22336945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]